Daniel A Arber

39PUBLICATIONS
207CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityHaematological tumoursPredictive and prognostic markersMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Nov 12, 2025
Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141).

Robert Jeraj, Fenghai Duan, Ryan J Mattison

|Oct 30, 2025
Rare composite of Rosai-Dorfman-Destombes disease and nodular lymphocyte-predominant B-cell (Hodgkin) lymphoma.

Madhavi Pandiri, Daniel A Arber

|Oct 18, 2025
Acute Leukemias of Ambiguous Lineage With RUNX1 Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With RUNX1 Mutations: A Study From the Bone Marrow Pathology Group.

Timothy J Kirtek, Weina Chen, Jaryse C Harris

|Aug 14, 2025
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.

Ethan J Harris, Diren Arda Karaoglu, Madina Sukhanova

|Jul 03, 2025
Systemic Mastocytosis in 910 Patients: Prognostic Contribution of the International Consensus Classification in the Context of the Mayo Alliance Prognostic System.

Fnu Aperna, Maymona G Abdelmagid, Mahesh Kumar

|May 07, 2025
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort.

Mithun Vinod Shah, Kevin Hung, Anmol Baranwal

Pageof 7

Frequent Collaborators

15 joint publications

Attilio Orazi

13 joint publications

Ayalew Tefferi

10 joint publications

Naseema Gangat

8 joint publications

Mithun Vinod Shah